Skip to main content

JPMORGAN CHASE & CO

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in LCTX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$17,290
+$1,619 QoQ
Shares Held
10,944
+16.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. LCTX ranks #288 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LCTX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $17,290 10,944
2025-12-31 $15,671 9,384
2025-09-30 $22,592 13,369
2025-06-30 $20,909 22,979
2025-03-31 $272,267 605,044
2024-12-31 $473,198 946,399
2024-09-30 $616,215 677,162
2024-06-30 $594,298 594,298
2024-03-31 $1,000,040 675,704
2023-12-31 $792,442 727,013
2023-09-30 $837,183 709,478
2023-06-30 $1,467,086 1,040,487
2023-03-31 $1,668,166 1,112,111
2022-12-31 $1,273,636 1,088,579
2022-09-30 $1,185,426 1,049,051
2022-06-30 $1,985,951 1,256,932
2022-03-31 $2,848,479 1,849,662
2021-12-31 $3,144,027 1,283,277
2021-09-30 $5,583,795 2,215,792
2021-06-30 $5,563,507 1,952,108
2021-03-31 $171 73
2020-12-31 $3,980 2,262
2020-09-30 $11,790 12,544
2020-06-30 $4,815 5,536
2020-03-31 $148,441 178,846